Successful Transitions and Reintegration Tools for Veterans (START-VETS)

NCT ID: NCT04366531

Last Updated: 2025-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-03

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will develop prison reentry materials for Veterans leaving prison.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be conducted in three phases Phase 1 is to collect qualitative data from Veterans who have recently been released from prison. The data will focus on their transition experience, stigma (both self and from others), and behaviors that interfered with success.

Phase 2a will be to develop a transition program based around the needs identified in phase 1 Phase 2b will be to develop assessment tools to be used with the program Phase 3 will be to perform a two group randomized cross over design pilot study to assess the program

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance Use Disorder Mental Illness Recently Incarcerated

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Veterans will be randomly assigned to either begin an eight week (actual number of weeks is to be determined based on phase 2) active treatment program or to a no treatment phase. At eight weeks veterans will switch the condition they were assigned.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Monitoring/Treatment as usual

Veterans will not receive any study related interventions.

Group Type NO_INTERVENTION

No interventions assigned to this group

Reentry Program

Veterans will receive the START-VET reentry program

Group Type ACTIVE_COMPARATOR

START-VET

Intervention Type BEHAVIORAL

prison reentry program

Treatment as usual

Intervention Type OTHER

This intervention involves no additional services above what is provided by the local health care system

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

START-VET

prison reentry program

Intervention Type BEHAVIORAL

Treatment as usual

This intervention involves no additional services above what is provided by the local health care system

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Veteran with mental illness and/or substance use disorder released from prison within the past 36 months

Exclusion Criteria

* psychosis or cognitive impairment precluding active participation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James P. LePage, PhD

Role: PRINCIPAL_INVESTIGATOR

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

Dallas, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

April Crawford, MS

Role: CONTACT

(214) 857-2571

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

April Crawford, MS

Role: primary

214-857-2571

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D3225-R

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Buprenorphine for Prisoners
NCT00574067 COMPLETED PHASE3
Coaching for HCV and HIV
NCT04314414 COMPLETED NA
HMP for Addictions Study
NCT06063499 WITHDRAWN NA
CBT4CBT for Office Based Buprenorphine
NCT03580902 COMPLETED PHASE1/PHASE2
New Beginnings Following Trauma
NCT05817344 TERMINATED NA